Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
about
Epidemics to eradication: the modern history of poliomyelitisA Brief Review of Computer-Assisted Approaches to Rational Design of Peptide VaccinesCalibration of multiple poliovirus molecular clocks covering an extended evolutionary rangeEvidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradicationThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseSynthetic DNA vaccine strategies against persistent viral infectionsA large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence.Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.Estimating the extent of vaccine-derived poliovirus infection.Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses.Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region.Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornavirusesA Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding regionIntratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological propertiesHigh frequency and diversity of species C enteroviruses in Cameroon and neighboring countries.Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.Characteristics of an environmentally monitored prolonged type 2 vaccine derived poliovirus shedding episode that stopped without interventionCross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus caseAn aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5' Untranslated Region.Circulation of multiple serotypes of highly divergent enterovirus C in the Xinjiang Uighur Autonomous Region of China.Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus Agent.Genetic diversity and molecular characterization of enteroviruses from sewage-polluted urban and rural rivers in the PhilippinesAn Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.Detection of non-polio enteroviruses from 17 years of virological surveillance of acute flaccid paralysis in the Philippines.Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaChanges in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patientReemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.Multiplex PCR method for identifying recombinant vaccine-related polioviruses.Role of environmental poliovirus surveillance in global polio eradication and beyond.Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).
P2860
Q21245132-A82B8B2B-15BC-4B80-BABD-19F88866CC47Q24261117-1F17D737-19D4-43B6-821F-C65B9F7E772DQ24655520-10BD4EF1-73C0-4B92-9BCE-C83738651BE4Q24683132-C08CA3E6-F6FC-4995-8DE4-447F71ACBB24Q26995782-5CA23D48-FAD2-4272-9C70-E161EB867FDFQ27016078-BFED492E-EBF6-46B6-9556-7CEE3F44BE62Q30840117-AD78E82D-7870-47B0-81B9-6296B4718E15Q31034162-0371D3B1-E649-41C0-94F0-2F2A5182EBD3Q33310740-E50DA398-0CAB-4D18-8C9E-6B042E71A181Q33346729-B4C09654-5298-43C7-8711-B5AB83E3ED5EQ33380220-07A38E8C-555D-4BD8-BBCA-A7CCBA30C0E2Q33381395-121C64D0-F690-4D1D-B087-0EDDCF73E013Q33438422-810D07B5-0BBD-48C3-AC7B-D48D0F4F17C9Q33784842-4C4F9933-7ECA-422F-BE4E-CDC1A95B6D09Q33899399-7172A8DF-D2BA-4A93-A07A-C33408625129Q34026234-D29D73C4-9F68-4D05-9DC0-9904D276E192Q34045638-19A3F33B-B63C-4F5D-B81A-4CCB57023D66Q34045658-C397422C-DB48-4DB8-BD19-BF1965FF42F2Q34120449-3FCFDA34-C26F-4CF5-8B0D-0AC3DFE20E40Q34435032-5205EF33-E9C8-492A-A47B-8B979EF965EDQ34518473-3DC73B56-CD9C-464F-B3CD-81ACA490F498Q34743352-18E074DB-4BA5-4440-B132-549A718F844BQ34917653-05B46E68-BD02-4022-9448-CD602254A613Q35021433-4A7F886E-2A77-4960-B951-1C4C4EA03E77Q35025154-4A67A40E-5896-4CA2-900F-934F814D9B77Q35220868-DB73C0DD-CE26-4AF8-9DA0-08F35CA68FFBQ35757398-9C4C4AB6-AE58-4E84-BD64-87F5581F2DAEQ35839763-891C6D05-E613-4346-96A4-83C06B469A92Q36136883-0027C8C2-BA1A-4C5A-91F9-7E9CA896553CQ36161679-AB7C8DB6-7BF3-4594-89FD-CDA39598A956Q36252818-4FB74E93-9D64-406C-921F-42120E26C607Q36316673-2210A990-D2BD-40A9-829B-B303B3D947E2Q36406152-A713CD6F-D6DB-4027-9945-7C30D0083259Q36760045-DFCF3048-6EF9-4104-BBF1-C7C3D2AEC958Q36898727-D6B1A4F9-CED2-4F0B-AE3B-A8FF50509DBBQ37410530-EC5A92D7-C590-4B5E-BFDE-D8B2E6338B37Q37511244-2707A2D0-59F9-4D00-9741-FBE45F64B8F1Q37919182-2833F3A2-2F6A-45DE-99DC-DBE4961BF6C2Q38028997-2772D46B-6C29-4832-A6E2-0801220FB55BQ38087428-C9475BEF-7614-4ED0-9C9E-137D8DE57EC4
P2860
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@ast
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@en
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@nl
type
label
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@ast
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@en
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@nl
prefLabel
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@ast
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@en
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@nl
P2093
P2860
P50
P3181
P1433
P1476
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
@en
P2093
Agnes Benegas
Andi Utama
Fem Julia Paladin
Hiroyuki Shimizu
Kerri Anne Brussen
Lilly Yuen
Sigrun Roesel
Tatsuo Miyamura
Tetsuo Yoneyama
P2860
P304
P3181
P356
10.1128/JVI.78.24.13512-13521.2004
P407
P577
2004-12-01T00:00:00Z